Cybin (CYBN) Gets a Buy From H.C. Wainwright
Sunrun, HubSpot, Rocket, Summit, Cybin: Trending by Analysts
Cybin Price Target Announced at $35.00/Share by Guggenheim
Cybin Analyst Ratings
Guggenheim Initiates Cybin(CYBN.US) With Buy Rating, Announces Target Price $35
A. G. P. Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $25
Analysts Offer Insights on Healthcare Companies: Cybin (CYBN) and Corbus Pharmaceuticals (CRBP)
Cybin Price Target Cut to $73.00/Share From $86.00 by Canaccord Genuity
Cybin Is Maintained at Buy by Canaccord Genuity
Cybin Analyst Ratings
CCORF Maintains Cybin(CYBN.US) With Buy Rating, Cuts Target Price to $73
HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $190 Price Target
Cybin Analyst Ratings
Cybin Is Maintained at Buy by Canaccord Genuity
CCORF Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $86
Optimistic Buy Rating for Cybin: Promising CYB003 Phase 2 Results and Market Potential
Cybin Analyst Ratings
Cybin Is Maintained at Buy by Canaccord Genuity
Cybin Analyst Ratings
A. G. P. Initiates Cybin(CYBN.US) With Buy Rating, Announces Target Price $25